Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Alzheimer's disease pathogenesis involves amyloid-beta (Aβ) deposition.
• Transgenic mouse models are crucial for studying Alzheimer's disease mechanisms.
• APP(V717F) mutation is linked to familial Alzheimer's disease.

Purpose of the Study:

• To investigate the relationship between amyloid deposition, neuroanatomical changes, and cognitive deficits in APP(V717F) transgenic mice.
• To determine the age-dependent progression of neuropathology in these mice.
• To differentiate the contributions of amyloid plaques and other neuroanatomical alterations to behavioral impairments.

Main Methods:

• Histological analysis of brain tissue from APP(V717F) transgenic mice (heterozygous and homozygous).
• Quantification of amyloid deposition using immunohistochemistry.
• Measurement of synaptic density via synaptophysin immunoreactivity.
• Assessment of hippocampal volume to detect atrophy.
• Correlation analysis between neuropathological findings and behavioral test results (object recognition, spatial memory).

Main Results:

• Age-dependent amyloid deposition was observed in both heterozygous and homozygous APP(V717F) Tg mice.
• Significant, age-dependent decreases in synaptic density were detected.
• Marked hippocampal atrophy (20-40%) was evident as early as 3 months of age.
• Object recognition deficits correlated with regional amyloid load.
• Spatial memory deficits correlated with synaptic density and hippocampal atrophy.

Conclusions:

• Behavioral deficits in APP(V717F) Tg mice are multifactorial.
• Amyloid deposition contributes partially to cognitive impairments.
• Neuroanatomical alterations, including hippocampal atrophy and synaptic loss, play a significant role, independent of amyloid burden.
• Overexpression of the APP(V717F) transgene can induce neurodegenerative changes beyond amyloidosis.